GV20

Customer Profile

GV20 Oncotherapy (GV20 Bio) is a biotechnology company focused on the research and development of precision cancer therapies with a unique focus on novel target identification and antibody drug discovery in immuno-oncology, founded in 2016 and headquartered in Shanghai, China, with a branch office in the United States.

Business Challenges

1. Satisfy the internationalisation (Chinese and American markets) integration management requirements;
2. GSP/GMP management requirements;
3. R & D, cost and inventory management;
4. Future global trade expansion requirements.

Solution

1. NetSuite internationalisation and conglomerate attributes naturally meet GV20 conglomerate internationalisation management requirements;
2. NetSuite meets the management requirements of GSP and GMP, batch traceability of materials, semi-finished products and finished products, and inventory maintenance;
3. R & D stage management: R & D stage (no product has entered the late stage of clinical), project management in the R & D process, R & D cost management such as materials, labour and fees, inventory management and inventory maintenance of the two subsidiaries in the United States and China;
4. Procurement Management: Support the procurement of both physical goods and services, including CRO services, with milestone-based virtual goods receipt and payment.
5. Overseas Sales Management: Currently supports patent licensing and sales, with pilot programs for physical product sales now underway.
6. Hitpoint’s Growth-Oriented Support Services: Hitpoint provides ongoing consulting and process implementation support throughout every stage of the client’s business development—from multi-category procurement, inventory management, and cost and expense management during the R&D phase to the expansion of global trade operations.